Skip to main content
Download PDF

Electroacupuncture reduces inflammatory damage following cerebral ischemia–reperfusion by enhancing ABCA1-mediated efferocytosis in M2 microglia

Molecular Brain volume 17, Article number: 61 (2024) Cite this article

Abstract

Ischemic stroke (IS) is a severe cerebrovascular disease with high disability and mortality rates, where the inflammatory response is crucial to its progression and prognosis. Efferocytosis, the prompt removal of dead cells, can reduce excessive inflammation after IS injury. While electroacupuncture (EA) has been shown to decrease inflammation post-ischemia/reperfusion (I/R), its link to efferocytosis is unclear. Our research identified ATP-binding cassette transporter A1 (Abca1) as a key regulator of the engulfment process of efferocytosis after IS by analyzing public datasets and validating findings in a mouse model, revealing its close ties to IS progression. We demonstrated that EA can reduce neuronal cell death and excessive inflammation caused by I/R. Furthermore, EA treatment increased Abca1 expression, prevented microglia activation, promoted M2 microglia polarization, and enhanced their ability to phagocytose injured neurons in I/R mice. This suggests that EA's modulation of efferocytosis could be a potential mechanism for reducing cerebral I/R injury, making regulators of efferocytosis steps a promising therapeutic target for EA benefits.

Introduction

IS is a disease caused by decreased cerebral blood flow, resulting in damage to brain tissue in the area supplied with blood, and accounts for approximately 62.4% of all stroke cases and 87% of all stroke deaths [1, 2]. The primary clinical interventions for IS presently involve intravenous thrombolysis with tissue plasminogen activator (tPA) and endovascular thrombectomy [3]. However, both therapies are limited by a strict time window, and revascularization may still lead to neurological damage known as cerebral I/R injury [4, 5]. Inflammatory injury is the primary pathological alteration in I/R injury, exacerbating secondary brain injury mainly by causing blood–brain barrier disruption, brain edema, and oxidative stress [6, 7]. This injury severely affects the prognosis of stroke patients and could exacerbate both disability and mortality rates [8, 9].

Microglia are the primary immune cells in the brain, serving as the first line of defense in protecting the nervous system against damage [10]. Two distinct polarization phenotypes are identifiable in microglia activated after ischemic stroke: the pro-inflammatory M1, which exerts neurotoxic effects, and the anti-inflammatory M2, which is neuroprotective [11]. Recent studies demonstrate that the process of phagocytosis and removal of dead or dying cells and debris, also known as efferocytosis, is crucial for microglia in exerting neuroprotective effects and promoting post-ischemic brain tissue repair [12, 13]. Efferocytosis helps prevent the release of damage-associated molecular patterns (DAMPs) and reduces the exaggerated inflammatory response, which is essential for restructuring neural circuits and the central microenvironment following I/R injury [14]. Additionally, impaired microglial efferocytosis results in an exacerbated inflammatory response that hinders the neurological recovery following I/R injury [15]. Therefore, a deep study of the function of microglial efferocytosis represents a novel approach to I/R therapy.

As a traditional Chinese therapy with thousands of years of history, acupuncture has been widely used to treat ischemic stroke, due to its safety and effectiveness [16, 17]. The existing research evidence suggests that EA, which combines traditional acupuncture with electrical stimulation, can enhance treatment outcomes and mitigate cerebral I/R injury and associated neurological deficits by suppressing the inflammatory response [18,19,20]. However, it remains unclear whether efferocytosis, a crucial process in regulating inflammatory responses during cerebral ischemic injury, serves as the primary mechanism by which EA modulates the anti-inflammatory effects of microglia. In the present study, we used bioinformatics methods to screen genes associated with efferocytosis after cerebral ischemic injury. In addition, a middle cerebral artery occlusion/reperfusion (MCAO/R) model has been established to mimic I/R injury, and western blot (WB), reverse transcription-quantitative PCR (RT-qPCR) and Immunofluorescence (IF) analyses were performed to explore the relationship between EA and efferocytosis in promoting functional recovery after cerebral ischemia/reperfusion.

Methods

Bioinformatic analysis

The gene list in the article for the three processes of efferocytosis, "find me", "eat me", and "engulf me", was created by combining references to gene lists associated with efferocytosis [21,22,23]. The data for the bioinformatic analyses were obtained from the public repository NCBI GEO (http://www.ncbi.nlm.nih.gov/geo), and datasets GSE30655 and GSE174574 were used in the study. The protein–protein interaction network (PPI) of differentially expressed genes (DEGs) associated with efferocytosis was generated using the STRING database and visualized using Cytoscape. The single-cell RNA-sequencing (scRNA-seq) dataset was visualized using UMAP plots.

Animals and groups

C57BL/6J mice were used in this study (male, aged 6–8 weeks, weighing 20–25 g), and were supplied by GemPharmatech Co., Ltd., Chengdu, China (license No. SCXK (Chuan) 2020-034). Mice were housed in well-ventilated cages under 12 h light/dark cycle at a temperature of 25 ± 1 °C and humidity of 50 ± 5% with adequate food and water. The mice were randomly and equally assigned to the sham, I/R, and EA groups, with the experimenters blinded to the groups. During the experiment, any mice that perished or did not meet the inclusion criteria were removed, and the number of mice in each group was replenished using the same modeling procedure. All animal experimentation procedures were approved by the Animal Ethics Committee of the Hospital of Chengdu University of Traditional Chinese Medicine (No.2023DL-022).

Mouse model of I/R

The I/R model was established using a modified Zea-Longa method [24]. We anesthetized the mice in an anesthesia induction box containing 5% isoflurane in oxygen/air mixture, then transferred them to an anesthesia mask to maintain anesthesia with 2% isoflurane (RWD Life Science, Shenzhen, China) from the animal anesthesia machine (R500, RWD Life Science, Shenzhen, China). The median neck muscle was divided, exposing the left common carotid artery (CCA), external carotid artery (ECA), and internal carotid artery (ICA). Litigation of the CCA proximal end and the ECA was performed permanently and ICA distal ends clamped with arterial clips to temporarily block blood flow to the brain. Then a monofilament (MSMC21B120PK50, RWD Life Science, Shenzhen, China) was placed inside the internal carotid artery by making an incision in the left common carotid artery to occlude the origin of the middle cerebral artery. MCAO for 60 min was followed by suturing of the wound to restore blood flow. During surgery, a heating pad was adopted to maintain the mice's body temperature at 37 °C. The sham group exposed only the left side of the vessel without monofilament insertion.

EA treatment

EA was given to the mice in the EA group 24 h after I/R. The mice were anesthetized using a mask with 2% isoflurane and then inserted with stainless acupuncture needles (0.18 mm × 13 mm, Huatuo, Suzhou, China) into the right ST36 (Zusanli, located longitudinally at 3 cun below the knee joint and intersecting the middle of the tibialis anterior muscle) and GV20 (Baihui, located at the intersection of the sagittal midline with the line between the ears). The parameters of the EA consisted of dispersive waves with a frequency of 2/15 Hz, an intensity of 1 mA, and a duration of five consecutive days with 20 min per day. The sham group and the I/R group received anesthesia only, without electroacupuncture.

Neurological deficit assessment

After 24 h of I/R in mice, neurological deficits were measured by an investigator who was blinded to the experimental groups. The specific scoring criteria are based on the Zea Longa five-point scale, as illustrated in Table 1 [24]. Mice that scored 1 to 3 points were considered successful in modeling and each mouse was scored daily for five consecutive days.

Table 1 Zea-Longa score
Full size table

Infarct area measurement

At the end of the fifth day of neurological scoring, brain tissues were collected for 2,3,5-triphenyl tetrazolium chloride (TTC, Sangon Biotech, Shanghai, China) staining. The brain tissues were frozen at − 20 °C for 20 min. Each brain was cut into seven coronal sections at 1 mm intervals, then immersed in 2% TTC solution and incubated at 37 °C for 15 min protected from light, followed by 4% paraformaldehyde solution (Servicebio, Wuhan, China) immersion. The non-ischemic tissue showed a red color, while the infarcted areas were white. The infarct area and total area of the six sections were determined using ImageJ software, and the following formula was used to calculate the percentage of infarct area:( total infarct area/total area of slice) × 100%.

Histopathological observation

After 4% paraformaldehyde fixation, the brain containing hippocampal tissue was dehydrated, embedded in paraffin, and coronally sectioned. Sections were stained with Nissl staining solution (Servicebio, Wuhan, China) and Hematoxylin–Eosin staining kit (Servicebio, Wuhan, China), respectively. A light microscope (Nikon Eclipse E100, Nikon, Tokyo, Japan) was used to examine the pathological changes of cortex and hippocampus tissues.

Multiplex immunofluorescence staining

Paraffin-embedded sections were washed in distilled water after they had been deparaffinized. The antigen was repaired using a microwave with ethylene diamine tetraacetic acid (EDTA, PH8.0, C1033, Solarbio, Beijing, China) antigen repair buffer. Sections were pretreated with 3% H2O2 for 10 min to block endogenous peroxidase activity and incubated in 3% (w/v) bovine serum albumin-V (BSA-V, A8020, Solarbio, Beijing, China) in Phosphate Buffered Saline (PBS, Servicebio, Wuhan, China) for 30 min at room temperature (RT). The following antibodies were used as primary antibodies at 1:200 dilution in PBS overnight at 4 °C: anti-Iba1 (ab178846, Abcam, Cambridge, UK), anti-CD206 (GB113497-100, Servicebio, Wuhan, China), anti-NeuN (A19086, ABclonal, Wuhan, China), and anti-Abca1 (A21976, ABclonal, Wuhan, China). Wash with PBS and incubate with anti-rabbit IgG antibody 1: 400 (FCMCS, FMS-Rb01) for 50 min at RT in the dark. The following fluorescent dyes were applied to the sections: IF488-Tyramide (G1236-1, Servicebio, Wuhan, China), IF555-Tyramide (G1236-2, Servicebio, Wuhan, China), and IF647-Tyramide (G1236-3, Servicebio, Wuhan, China). Incubations were shielded from light for 10 min. Multiplex staining was repeated in series for each staining step, and antigen repair was performed between each staining step. The sections were subsequently incubated with 4′,6-diamidino-2-phenylindole (DAPI, G1236-5, Servicebio, Wuhan, China) for 10 min at RT in the dark, washed, and sealed with an anti-fluorescence quenching sealer (G1401-5, Servicebio, Wuhan, China) finally. These brain sections were observed with Nikon Eclipse E100. ImageJ software was used to count the number of positive cells.

Western blot

The hippocampus and parietal cortex were extracted from the mouse brain and weighed, and a BCA protein assay kit (BL521A, Biosharp, Beijing, China) was used to determine protein concentration. Each sample contained 15–50 μg of protein, which was electrophoresed on a sodium dodecyl sulfate–polyacrylamide gel and then transferred to PVDF membranes (IPVH00010, 0.45 µm, Millipore, Immobilon, Ireland). The membranes were blocked with 5% (w/v) skimmed milk in tris buffered saline with Tween-20 (TBST) buffer for 2 h. After washing with TBST, the membranes were incubated at 1:1000 dilution in TBST overnight at 4 °C with the following antibodies: anti-Iba1 (ab178846, Abcam, Cambridge, UK), anti-CD206 (A8301, ABclonal, Wuhan, China), anti-NeuN (A19086, ABclonal, Wuhan, China), anti-Abca1 (A21976, ABclonal, Wuhan, China), anti-GAPDH(GB12002, Servicebio, Wuhan, China). After washing with TBST, the secondary antibody diluent of the corresponding species of the primary antibody, goat anti-rabbit IgG antibody (FMS-Rb01, FCMCS, Nanjing, China) or mouse (FMS-MS01, FCMCS, Nanjing, China), was added and incubated for 1.5 h at RT. An enhanced chemistry luminescence (ECL, BL520A, Biosharp, Beijing, China) method was used to detect protein bands after the membranes were again washed. The intensity of the bands was analyzed using ImageJ software.

RNA extraction and RT-qPCR analysis

The cortex and hippocampus of the mice were promptly flash-frozen in liquid nitrogen and stored at − 80 °C after extraction. Total RNA was extracted using the MolPure Cell/Tissue Total RNA Kit (Yeasen Biotechnology, Shanghai, China), and purity and concentration were determined using the Nanodrop 2000 UV–visible spectrophotometer. RNA is reverse transcribed to cDNA using Hifair III 1st Strand cDNA Synthesis SuperMix for qPCR (Yeasen Biotechnology, Shanghai, China). Subsequently, RT-qPCR analysis was conducted utilizing the primers listed in Table 2, based on the Hieff UNICON® Universal Blue qPCR SYBR Green Master Mix (Yeasen Biotechnology, Shanghai, China). For detailed procedures, please refer to the corresponding kit instructions. The primer sequences utilized for amplification are displayed in Table 2, provided by Sangong Biotech (Sangong Biotech, Shanghai, China).

Table 2 RT-qPCR primer sequences
Full size table

Statistical analyses

All data were analyzed using either GraphPad Prism v.9.5.0 or R software and expressed as mean ± standard error of the mean. Survival curves were compared using the Log-rank test. Tukey's multiple comparisons test was used to test for differences in percentage weight change and Neurological Deficit. Other data that followed a normal distribution with homogenous variance were analyzed using One-way analysis of variance for multiple comparisons. P-values less than 0.05 were deemed statistically significant.

Results

EA treatment improved survival outcomes, neurologic deficits, and reduced infarct area in I/R Mice

The experimental flow chart is illustrated in Fig. 1a. To assess the protective effects of EA in mice model of I/R, we monitored weight, survival rate, neurological deficit scores, and percentage of cerebral infarct volume of the mice throughout the experimental period. The results indicated that the I/R model mice experienced a significant decline in weight and a shorter survival time compared to the sham group; compared to the I/R group, the EA group demonstrated a noteworthy deceleration in the reduction of their body weight (P < 0.0001) and exhibited an observable increase towards a survival rate (P = 0.0331) (Fig. 1b, c). Neurological impairment is one of the main adverse outcomes following I/R injury. Mice in the sham group did not show any neurobehavioral dysfunction, whereas those in the I/R group showed significant neurological deficits; EA treatment was effective in the reduction of neurological deficit scores (P < 0.0001) (Fig. 1d). Additionally, we assessed the infarct area through TTC staining and observed that EA intervention proved to be effective in reducing infarct injury (P = 0.0002) (Fig. 1e). These findings suggested that EA was effective in reducing infarct size, improving prognosis, and providing neuroprotection in I/R mice.

Fig. 1
figure 1

Electroacupuncture increased survival rates, improved neurologic function, and reduced cerebral infarct area in I/R Mice. a Flowchart of the animal experiment (n = 9/group). b Body weight change curve (n = 9/group). c Survival curve d Neurological deficit score (n = 9/group). e TTC staining images and percentage of infarct area ratio(n = 3/group). *P < 0.05, **P < 0.01, compared with the sham group; #P < 0.05, ##P < 0.05, compared with the I/R group

Full size image

EA treatment attenuated I/R-induced neuronal loss

As neuronal injury releases DAMPs that can worsen the inflammatory cascade, we assessed the impact of EA on neuronal injury induced by I/R. Pathological findings of the cerebral cortex and hippocampus were conducted using Nissl staining. The results showed that the neurons in the sham group had intact morphology, neat arrangement, and uniform staining; the number of neurons in the I/R group significantly decreased, and the histological alterations revealed abnormal morphology, disorganized arrangements, and reduced Nissl bodies; in the EA group, Nissl bodies were more abundant and neuronal damage and loss were reduced (Fig. 2a). IF staining showed that the number of NeuN-positive cells significantly decreased after I/R, whereas the EA group showed an increase in comparison with the I/R group in the hippocampal area (P = 0.0008) (Fig. 2b). Additionally, both WB and RT-qPCR results revealed a significant decrease in the expression of the neuronal marker NeuN at both protein and transcript levels in the brains of mice in the I/R group compared to those in the sham group; EA treatment resulted in an upregulation of NeuN expression compared to the I/R group (P = 0.0100 in WB, P = 0.0163 in PCR) (Fig. 2c, d). The results suggested that EA treatment attenuated I/R-induced neuronal loss.

Fig. 2
figure 2

Electroacupuncture attenuated I/R-induced neuronal loss. a Nissl staining of the cerebral cortex and hippocampus (Arrows indicate representative damaged neurons) (bar = 100 μm). b IF images of NeuN (green) and quantification of the number of NeuN-positive cells in the hippocampus; nuclei were counterstained with DAPI (blue) (bar = 50 μm; n = 3/group). c Western blotting bands of NeuN and its relative protein level (n = 6/group). d RT-qPCR for the relative level of NeuN mRNA (n = 6/group). *P < 0.05, **P < 0.01, compared with the sham group; #P < 0.05, ##P < 0.05, compared with the I/R group

Full size image

Efferocytosis-related gene Abca1 expression is upregulated after cerebral ischemia

After cerebral ischemic injury, efferocytosis rapidly engulfs and removes dead cells, which is critical to preventing excessive inflammatory responses and reducing secondary ischemic injury [25]. Efferocytosis is a process that includes three stages: "find me", "eat me", and "engulf me", and these markers have been classified individually through an analysis of the relevant literature [21,22,23] (Fig. 3a). Using the STRING database, the PPI network of DEGs associated with efferocytosis was visualized in Cytoscape (Fig. 3b). Through analyzing data from a publicly available database, we discovered increased expression of Abca1, a key regulator of the engulfment process, after cerebral ischemic injury (Fig. 3c). Microglia are the primary immune cells of the central nervous system and play an important role in the regulation of central inflammation. ScRNA-seq analysis revealed a specific expression of Abca1 in the microglia (Fig. 3d, e). Based on the above results of the bioinformatics analysis, it is hypothesized that the Abca1-mediated efferocytosis process in microglia may play an important role in the reduction of inflammatory injury.

Fig. 3
figure 3

The analysis of efferocytosis-related genes from a publicly available database. a Summary of efferocytosis-related genes. b PPI network of efferocytosis-related genes. c The Violin plot of Abca1 expression. d UMAP plot, single-cell clusters colored by the cell type classification. e UMAP plot, showing the distribution of Abca1 expression

Full size image

EA treatment inhibited microglial activation and upregulated Abca1 expression

To investigate the aforementioned hypothesis, we employed HE staining to observe that the brain tissue of the I/R group showed significant inflammatory cell infiltration and cytoplasmic vacuolization, especially in the hippocampus region, and EA treatment effectively attenuated these pathological changes (Fig. 4a). WB and RT-qPCR were used to analyze the expression of Iba1 and Abca1 to evaluate the anti-inflammatory effects of EA in the I/R model. Iba1 expression significantly increased following I/R, while EA treatment effectively suppressed the upregulation of Iba1 (P = 0.0083 in WB, P = 0.0091 in PCR) (Fig. 4b, c). Analysis of the IF staining, it was observed that microglia in the Sham group had minimal expression while microglia in the I/R group exhibited significant activation, as indicated by an increase in the number of Iba1-positive cells and an enlargement of the cell body. This activation was successfully inhibited by EA (P = 0.0088) (Fig. 4d). Similarly, we analyzed Abca1 using the same methodology and found that EA significantly increased expression (P = 0.0379 in WB, P = 0.0196 in PCR), while the distinction between the I/R group and the sham group was not significant (Fig. 4e, f). The above results suggested that EA treatment could diminish inflammatory injury, and this effect was linked to microglia activation inhibition and ABCA1 expression promotion.

Fig. 4
figure 4

Electroacupuncture alleviated I/R inflammatory injury, suppressed microglial activation, and increased Abca1 expression. a HE staining of the cerebral cortex and hippocampus (Arrows indicate representative inflammatory cells) (bar = 100 μm). b Western blotting bands of Iba1 and its relative protein level (n = 6/group). c RT-qPCR for the relative level of Iba1 mRNA (n = 6/group). d IF images of Iba1 (green) and quantification of the number of Iba1-positive cells in the hippocampus; nuclei were counterstained with DAPI (blue) (bar = 50 μm; n = 3/group). e Western blotting bands of Abca1 and its relative protein level (n = 6/group); f RT-qPCR for the relative level of Abca1 mRNA (n = 6/group). *P < 0.05, **P < 0.01, compared with the sham group; #P < 0.05, ##P < 0.01, compared with the I/R group

Full size image

EA treatment promoted neurological recovery by enhancing Abca1-mediated efferocytosis of M2 microglia

Due to the important role of anti-inflammatory M2 microglia in the protection of nerves affected by IS, we examined the expression of CD206, a specific marker for M2 microglia, in all groups of mice. The results showed that EA treatment elevated both protein (P = 0.0030) and transcript levels of CD206 (P = 0.0298) (Fig. 5a, b). Immunofluorescence double-labeling of Iba1 and CD206 was performed in mouse brain sections and, consistent with previous findings, the EA group raised the proportion of Iba1-CD206 double-positive cells to the number of Iba1-positive cells in comparison to the I/R group (P = 0.0360) (Fig. 5c). Therefore, the increased expression of M2 microglia could be a factor in the protective effect of EA against brain injury.

Fig. 5
figure 5

Electroacupuncture increased the expression of the CD206 marker of M2 microglia. a Western blotting bands of CD206 and its relative protein level (n = 6/group). b RT-qPCR for the relative level of CD206 mRNA (n = 6/group). c IF images of co-localization of Iba1 (green) and CD206 (pink) in the hippocampus and quantification of the number of Iba1-CD206 double-positive cells relative to the number of Iba1-positive cells; nuclei were counterstained with DAPI (blue) (bar = 50 μm; n = 3/group). *P < 0.05, compared with the sham group; #P < 0.05, ##P < 0.05, compared with the I/R group

Full size image

To further investigate the involvement of Abca1 expression in regulating the engulfment process of M2 microglia on injured neurons, we performed triple immunofluorescence labeling of mouse brain slices to detect the expression of Abca1, CD206, and NeuN. The IF staining results exhibited a substantial co-localization of Abca1, CD206, and NeuN in the I/R+ EA group as compared to the I/R group (P = 0.0243) (Fig. 6). In conclusion, EA treatment ameliorates I/R-induced neuronal damage by modulating Abca1-mediated efferocytosis in M2 microglia.

Fig. 6
figure 6

Electroacupuncture enhanced Abca1-mediated efferocytosis of M2 microglia. a IF images of co-localization of Abca1 (green), NeuN (red), and CD206 (pink) in the hippocampus and quantification of the number of Abca1-NeuN-CD206 triple-positive cells; nuclei were counterstained with DAPI (blue) (bar = 50 μm; n = 3/group). #P < 0.05, compared with the I/R group

Full size image

Discussion

The inflammatory response is a significant factor in cerebral ischemic injury and is closely associated with neurological dysfunction and can lead to complications such as post-stroke infections and multiorgan dysfunction affecting the lungs, intestines, and liver in post-stroke patients [26,27,28,29]. Furthermore, a severe inflammatory response is linked with death and poor outcomes in patients with ischemic stroke [30, 31]. The biological mechanisms causing inflammation are highly complex. In cerebral I/R injury, central inflammatory responses are activated due to the ischemic cascade, and inflammatory factors of peripheral origin can directly or indirectly act on the brain as a result of the disruption of the integrity of the blood–brain barrier, leading to neuronal damage or death [32, 33]. Injured or dead neurons exacerbate secondary brain damage by releasing endogenous molecules known as DAMPs, which amplify the neuroinflammatory response [34, 35]. These outcomes can seriously impede the functional recovery of stroke patients and ultimately lead to a higher mortality rate. Therefore, it is essential to inhibit the inflammatory response following a stroke to minimize brain damage and facilitate the recovery of function. Numerous research studies have shown that acupuncture can suppress inflammation in the central nervous system (CNS) and decrease damage to the brain; it is also recognized as a means to promote the recovery of sensory and motor nerve function after stroke and improve patients' quality of life [17, 36, 37]. The ST36 and GV20 are not only frequently chosen acupoints for clinical stroke treatment but have also been reported in basic research to improve ischemic injury through multiple pathways [36, 38]. In the theory of traditional Chinese medicine, GV20 belongs to the “Du meridian”, which plays a pivotal role in regulating the functional activities of the brain. It is often the primary acupoint used in the treatment of brain disorders. The ST36 point has been shown to have the effect of unblocking the meridians and collaterals, and it is believed to improve limb dysfunction after stroke. In this study, we confirmed that EA treatment at the ST36 and GV20 could reduce infarct area and inflammatory pathological changes, decrease neuronal loss, and ameliorate neurological deficits in I/R mice.

Abca1 is a membrane protein that plays a crucial role in high-density lipoprotein production and facilitates the removal of excess intracellular cholesterol and phospholipids [39]. Previous studies have demonstrated a significant upregulation in Abca1 mRNA expression in the blood of stroke patients, and that Abca1 promotes efferocytosis and provides anti-inflammatory protection against cerebral ischemic injury [40,41,42]. Through analyzing previous literature and open databases, we also got the similar result. Abca1 is closely linked to the regulation of efferocytosis after cerebral ischemia and is specifically expressed in microglia. Neuroinflammation is primarily mediated by microglia, which are highly responsive to brain changes, and cerebral ischemia rapidly triggers microglial activation to migrate to the site of injury and promote damage or recovery based on the polarization phenotype [43]. M1 microglia exacerbate ischemic tissue damage by producing inflammatory cytokines and cytotoxic substances, while in contrast, M2 microglia are capable of secreting anti-inflammatory cytokines, vascular endothelial growth factor, and other substances that attenuate inflammatory damage and promote cerebral vascular reconstruction and neural recovery [44]. Previous studies have shown that EA can mitigate neuroinflammation in the I/R model by promoting the polarization of microglia to the M2 phenotype through the regulation of the STAT6/PPARγ pathway and the expression and activity of ANXA1 [45, 46]. Our study results revealed similar findings that cerebral I/R injury resulted in microglial activation and a decrease in M2 expression, but treatment with EA reversed this change. Efferocytosis serves an important function in immune regulation, and microglia are the primary cells responsible for efferocytosis in the CNS [47]. Therefore, based on bioinformatics analysis results, we further investigated the expression levels of Abca1 in the I/R model. Our results indicated that EA treatment increased Abca1 expression, suggesting that the polarization of microglia may be regulated by EA treatment through the modulation of Abca1-mediated efferocytosis processes.

Effective efferocytosis not only helps phagocytes rapidly engulf and digest dead or dying cells, thereby protecting the microenvironment from the negative consequences of decaying cells, but also mitigates the body's inflammatory response through indirect means such as reducing pro-inflammatory signals and regulating macrophage phenotypes; conversely, impaired efferocytosis may lead to secondary necrosis of apoptotic cells and subsequently trigger an immune response [48, 49]. Since M2 microglia are essential for the recovery of neurological function after I/R injury due to their pivotal role in clearing debris, controlling secondary inflammatory responses, and accelerating tissue repair [50]. To further understand the impact of Abca1 on M2 microglia efferocytosis, we performed IF analyses. The results confirmed our hypothesis, which showed an increased co-expression of M2 microglia expressing Abca1 on their membranes with neurons after electroacupuncture treatment. In summary, our research indicated that electroacupuncture might have a beneficial impact on reducing inflammation and protecting against neurological damage by facilitating the Abca1-mediated phagocytosis of injured neurons by M2 microglial cells, referred to as the efferocytosis process.

It should be noted that this study has some limitations. First, we did not use the gene silencing technique for experimental validation. Second, our investigation focused only on the impact of Abca1, a crucial regulator of the efferocytosis engulfment process, and its role in Abca1-mediated phagocytosis of injured neurons by M2 microglia after cerebral I/R injury. The direct impact of Abca1 expression on microglia activation or polarization, as well as the role of Abca1 in linking apoptotic cells to efferocytosis, require further investigation. In addition, it is uncertain whether EA can regulate the efferocytosis of other phagocytes and the interactions between various types of phagocytes by modulating Abca1 expression, as Abca1 is expressed not only on microglia but also on other phagocytes, such as astrocytes. Future studies should include a more detailed research protocol to ensure complete, reliable, and valid experimental results.

Availability of data and materials

The data sets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Abbreviations

IS:

Ischemic stroke

I/R:

Ischemia/reperfusion

EA:

Electroacupuncture

tPA:

Tissue plasminogen activator

DAMPs:

Damage-associated molecular patterns

MCAO/R:

Middle cerebral artery occlusion/reperfusion

WB:

Western blot

RT-qPCR:

Reverse transcription-quantitative PCR

IF:

Immunofluorescence

PPI:

Protein–protein interaction network

DEGs:

Differentially expressed genes

scRNA-seq:

Single-cell RNA-sequencing

CCA:

Common carotid artery

ECA:

External carotid artery

ICA:

Internal carotid artery

TTC:

2,3,5-Triphenyl tetrazolium chloride

PBS:

Phosphate buffered saline

RT:

Room temperature

TBST:

Tris buffered saline with Tween-20

CNS:

Central nervous system

Abca1:

ATP-binding cassette transporter A1

References

  1. Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254–743.

    Article  PubMed  Google Scholar 

  2. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820.

  3. Warner JJ, Harrington RA, Sacco RL, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke. 2019;50(12):3331–2.

    Article  PubMed  Google Scholar 

  4. Xu P, Liu Q, Xie Y, et al. Breast cancer susceptibility protein 1 (BRCA1) rescues neurons from cerebral ischemia/reperfusion injury through NRF2-mediated antioxidant pathway. Redox Biol. 2018;18:158–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zeng X, Zhang YD, Ma RY, et al. Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis. Mil Med Res. 2022;9(1):25.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Jean WC, Spellman SR, Nussbaum ES, et al. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery. 1998;43(6):1382–96.

    CAS  PubMed  Google Scholar 

  7. De Meyer SF, Denorme F, Langhauser F, et al. Thromboinflammation in stroke brain damage. Stroke. 2016;47(4):1165–72.

    Article  PubMed  Google Scholar 

  8. Li D, Ai Y. Hydrogen saline suppresses neuronal cell apoptosis and inhibits the p38 mitogen-activated protein kinase-caspase-3 signaling pathway following cerebral ischemia-reperfusion injury. Mol Med Rep. 2017;16(4):5321–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Goebel U, Scheid S, Spassov S, et al. Argon reduces microglial activation and inflammatory cytokine expression in retinal ischemia/reperfusion injury. Neural Regen Res. 2021;16(1):192–8.

    Article  CAS  PubMed  Google Scholar 

  10. Dodiya HB, Kuntz T, Shaik SM, et al. Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes. J Exp Med. 2019;216(7):1542–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ma Y, Wang J, Wang Y, et al. The biphasic function of microglia in ischemic stroke. Prog Neurobiol. 2017;157:247–72.

    Article  CAS  PubMed  Google Scholar 

  12. Boada-Romero E, Martinez J, Heckmann BL, et al. The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol. 2020;21(7):398–414.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Yu F, Wang Y, Stetler AR, et al. Phagocytic microglia and macrophages in brain injury and repair. CNS Neurosci Ther. 2022;28(9):1279–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Nakahashi-Oda C, Fujiyama S, Nakazawa Y, et al. CD300a blockade enhances efferocytosis by infiltrating myeloid cells and ameliorates neuronal deficit after ischemic stroke. Sci Immunol. 2021;6(64): eabe7915.

    Article  CAS  PubMed  Google Scholar 

  15. Korns D, Frasch SC, Fernandez-Boyanapalli R, et al. Modulation of macrophage efferocytosis in inflammation. Front Immunol. 2011;2:57.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Yang A, Wu HM, Tang JL, et al. Acupuncture for stroke rehabilitation. Cochrane Database Syst Rev. 2016;2016(8): CD004131.

    PubMed  PubMed Central  Google Scholar 

  17. Zhang S, Wu B, Liu M, et al. Acupuncture efficacy on ischemic stroke recovery: multicenter randomized controlled trial in China. Stroke. 2015;46(5):1301–6.

    Article  CAS  PubMed  Google Scholar 

  18. Ulett GA, Han S, Han JS. Electroacupuncture: mechanisms and clinical application. Biol Psychiatry. 1998;44(2):129–38.

    Article  CAS  PubMed  Google Scholar 

  19. Long M, Wang Z, Zheng D, et al. Electroacupuncture pretreatment elicits neuroprotection against cerebral ischemia-reperfusion injury in rats associated with transient receptor potential vanilloid 1-mediated anti-oxidant stress and anti-inflammation. Inflammation. 2019;42(5):1777–87.

    Article  CAS  PubMed  Google Scholar 

  20. Wang Y, Chen Y, Meng L, et al. Electro-acupuncture treatment inhibits the inflammatory response by regulating γδ T and Treg cells in ischemic stroke. Exp Neurol. 2023;362: 114324.

    Article  CAS  PubMed  Google Scholar 

  21. Leifman H, Kühlhorn E, Allebeck P, et al. Abstinence in late adolescence–antecedents to and covariates of a sober lifestyle and its consequences. Soc Sci Med. 1995;41(1):113–21.

    Article  CAS  PubMed  Google Scholar 

  22. Mehrotra P, Ravichandran KS. Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov. 2022;21(8):601–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Chen W, Li L, Wang J, et al. The ABCA1-efferocytosis axis: a new strategy to protect against atherosclerosis. Clin Chim Acta. 2021;518:1–8.

    Article  CAS  PubMed  Google Scholar 

  24. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84–91.

    Article  CAS  PubMed  Google Scholar 

  25. Cai W, Dai X, Chen J, et al. STAT6/Arg1 promotes microglia/macrophage efferocytosis and inflammation resolution in stroke mice. JCI Insight. 2019;4(20): e131355.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Sun H, Li S, Xu Z, et al. SNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppression. J Neuroinflamm. 2022;19(1):1.

    Article  CAS  Google Scholar 

  27. Jiao JT, Cheng C, Ma YJ, et al. Association between inflammatory cytokines and the risk of post-stroke depression, and the effect of depression on outcomes of patients with ischemic stroke in a 2-year prospective study. Exp Ther Med. 2016;12(3):1591–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Zhong HH, Qu JF, Xiao WM, et al. Severity of lesions involving the cortical cholinergic pathways may be associated with cognitive impairment in subacute ischemic stroke. Front Neurol. 2021;12: 606897.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190(3):255–66.

    Article  CAS  PubMed  Google Scholar 

  30. Vila N, Castillo J, Dávalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke[J]. Stroke. 2000;31(10):2325–9.

    Article  CAS  PubMed  Google Scholar 

  31. Whiteley W, Jackson C, Lewis S, et al. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med. 2009;6(9): e1000145.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Denes A, Thornton P, Rothwell NJ, et al. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun. 2010;24(5):708–23.

    Article  CAS  PubMed  Google Scholar 

  33. Chu K, Yin B, Wang J, et al. Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus. J Neuroinflamm. 2012;9:69.

    Article  CAS  Google Scholar 

  34. Shichita T, Sakaguchi R, Suzuki M, et al. Post-ischemic inflammation in the brain. Front Immunol. 2012;3:132.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Gu Y, Chen J, Shen J. Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets. J Neuroimmune Pharmacol. 2014;9(3):313–39.

    Article  PubMed  Google Scholar 

  36. Wu P, Mills E, Moher D, et al. Acupuncture in poststroke rehabilitation: a systematic review and meta-analysis of randomized trials. Stroke. 2010;41(4):e171–9.

    Article  PubMed  Google Scholar 

  37. Chavez LM, Huang SS, MacDonald I, et al. Mechanisms of acupuncture therapy in ischemic stroke rehabilitation: a literature review of basic studies. Int J Mol Sci. 2017;18(11):2270.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kuang H, Zhu X, Chen H, et al. The immunomodulatory mechanism of acupuncture treatment for ischemic stroke: research progress, prospects, and future direction. Front Immunol. 2024;15:1319863.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Segrest JP, Tang C, Song HD, et al. ABCA1 is an extracellular phospholipid translocase. Nat Commun. 2022;13(1):4812.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Sung HY, Choi EN, Han J, et al. Protective role of ABCA1 in ischemic preconditioning is mediated by downregulation of miR-33-5p and miR-135-5p. Sci Rep. 2021;11(1):12511.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Yvan-Charvet L, Pagler TA, Seimon TA, et al. ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis. Circ Res. 2010;106(12):1861–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Yuan J, Liao YS, Zhang TC, et al. Integrating bulk RNA and single-cell sequencing data unveils efferocytosis patterns and ceRNA network in ischemic stroke. Transl Stroke Res. 2024. https://doi.org/10.1007/s12975-024-01255-8.

    Article  PubMed  Google Scholar 

  43. Guan X, Wang Y, Kai G, et al. Cerebrolysin ameliorates focal cerebral ischemia injury through neuroinflammatory inhibition via CREB/PGC-1α pathway. Front Pharmacol. 2019;10:1245.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Qin C, Zhou LQ, Ma XT, et al. Dual functions of microglia in ischemic stroke. Neurosci Bull. 2019;35(5):921–33.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Yao Z, Cai L, Zhao A, et al. Electroacupuncture alleviates neuroinflammation by regulating microglia polarization via STAT6/PPARγ in ischemic stroke rats. Neuroscience. 2023;532:23–36.

    Article  CAS  PubMed  Google Scholar 

  46. Zou J, Huang GF, Xia Q, et al. Electroacupuncture promotes microglial M2 polarization in ischemic stroke via annexin A1. Acupunct Med. 2022;40(3):258–67.

    Article  PubMed  Google Scholar 

  47. Zhao J, Zhang W, Wu T, et al. Efferocytosis in the central nervous system. Front Cell Dev Biol. 2021;9: 773344.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Kumar S, Birge RB. Efferocytosis. Curr Biol. 2016;26(13):R558–9.

    Article  CAS  PubMed  Google Scholar 

  49. Zhang J, Ding W, Zhao M, et al. Mechanisms of efferocytosis in determining inflammation resolution: therapeutic potential and the association with cardiovascular disease. Br J Pharmacol. 2022;179(23):5151–71.

    Article  CAS  PubMed  Google Scholar 

  50. Wu LH, Huang BR, Lai SW, et al. SIRT1 activation by minocycline on regulation of microglial polarization homeostasis. Aging. 2020;12(18):17990–8007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We acknowledge the efforts from all members in the team and the support provided by the National Natural Science Foundation of China and the Department of Science and Technology of Sichuan Province. We also thank Xiao-hua Peng for help with the experimental apparatus.

Funding

This study was supported by the National Natural Science Foundation of China (Grant No. 82305411), the National Clinical Medical Research Center of Chinese Medicine and Acupuncture (NCRCOP2023001), the Department of Science and Technology of Sichuan Province (Grant Nos. 2023NSFSC1822 and 24NSFSC0097), and the Postdoctoral Fellowship Program of CPSF (2023MD744131).

Author information

Authors and Affiliations

  1. Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, No. 1166 Liutai Avenue, Chengdu, 611137, Sichuan, China

    Yu-sha Liao, Tie-chun Zhang, Yu-qi Tang, Pei Yu, Ya-ning Liu, Jing Yuan & Ling Zhao

  2. Key Laboratory of Acupuncture for Senile Disease (Chengdu University of TCM), Ministry of Education, Chengdu, 611137, Sichuan, China

    Jing Yuan & Ling Zhao

  3. Clinical Research Center for Acupuncture and Moxibustion in Sichuan Province, Chengdu, 610075, China

    Ling Zhao

Authors
  1. Yu-sha Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tie-chun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-qi Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pei Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ya-ning Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jing Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ling Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YSL, JY, and LZ conceived and designed all experiments. YSL, JY, and TCZ performed the experiments. YSL, JY, YQT, PY, and YNL analyzed the data. YSL wrote the original draft manuscript, and JY and LZ revised the manuscript. LZ and JY administrated the project and provided the funding. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jing Yuan or Ling Zhao.

Ethics declarations

Ethics approval and consent to participate

All animal experimentation protocols were approved by the Ethics Committee of the Hospital of Chengdu University of Traditional Chinese Medicine (No. 2023DL-022).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liao, Ys., Zhang, Tc., Tang, Yq. et al. Electroacupuncture reduces inflammatory damage following cerebral ischemia–reperfusion by enhancing ABCA1-mediated efferocytosis in M2 microglia. Mol Brain 17, 61 (2024). https://doi.org/10.1186/s13041-024-01135-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13041-024-01135-0

Keywords

Molecular Brain

ISSN: 1756-6606